115 FRAIL-AF RANDOMISED CONTROLLED TRIAL: RESULTS FIGURE 2: CUMULATIVE INCIDENCE CURVE OF FIRST MAJOR OR CLINICALLY RELEVANT NON-MAJOR BLEEDING EVENT. Time since randomisation (days) At risk (cumulative events) NOAC 662 (0) 602 (31) 558 (69) 524 (91) 503 (101) VKA 661 (0) 613 (27) 584 (44) 562 (56) 545 (62) Shaded areas represent the 95% confidence intervals. NOAC: non-vitamin K antagonist oral anticoagulant; VKA: vitamin K antagonist. 7
RkJQdWJsaXNoZXIy MTk4NDMw